|
ECD expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.75949999914727E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.42649999485189E-08 |
| Normal-vs-Stage2 |
4.879300E-03 |
| Normal-vs-Stage3 |
9.227700E-04 |
| Normal-vs-Stage4 |
6.603500E-04 |
| Stage1-vs-Stage2 |
5.380000E-01 |
| Stage1-vs-Stage3 |
3.768600E-01 |
| Stage1-vs-Stage4 |
8.904600E-01 |
| Stage2-vs-Stage3 |
8.886000E-01 |
| Stage2-vs-Stage4 |
7.338800E-01 |
| Stage3-vs-Stage4 |
6.154200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.36990000349147E-08 |
| Normal-vs-AfricanAmerican |
1.801670E-04 |
| Normal-vs-Asian |
4.584300E-02 |
| Caucasian-vs-AfricanAmerican |
3.795200E-01 |
| Caucasian-vs-Asian |
6.658800E-01 |
| AfricanAmerican-vs-Asian |
9.074600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.3802996219664E-10 |
| Normal-vs-Female |
7.361700E-02 |
| Male-vs-Female |
9.55350000000355E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.13179999991797E-07 |
| Normal-vs-Extreme_Weight |
1.48669998534245E-09 |
| Normal-vs-Obese |
3.045400E-04 |
| Normal-vs-Extreme_Obese |
1.438340E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.588200E-01 |
| Normal_Weight-vs-Obese |
1.171440E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.115200E-01 |
| Extreme_Weight-vs-Obese |
2.344000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
9.985000E-01 |
| Obese-vs-Extreme_Obese |
2.736200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.151800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.04099999999707E-05 |
| Normal-vs-Age(61-80Yrs) |
1.40170000051398E-08 |
| Normal-vs-Age(81-100Yrs) |
3.07650000030968E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.148400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.896960E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.092100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.764200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.525600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.387400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.47599995851067E-09 |
| Normal-VS-Type2 PRCC |
2.31220000035393E-07 |
| Normal-VS-KIRP CIMP |
2.570800E-01 |
| Normal-VS-Unclassified PRCC |
4.673600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
8.566600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.770000E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.141700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
4.903800E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
6.743900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
4.462200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.48289999946094E-07 |
| Normal-vs-N1 |
2.683700E-02 |
| Normal-vs-N2 |
3.095800E-01 |
| N0-vs-N1 |
2.347800E-02 |
| N0-vs-N2 |
6.308800E-01 |
| N1-vs-N2 |
5.501400E-01 |
|
|
